2022 American Transplant Congress
Survival of the Fittest: The Rise in Liver Transplantation for Alcoholic Related Disease
*Purpose: The number of Orthotopic Liver Transplantation (OLT) performed for hepatitis C infection have decreased recently due to direct acting antiviral therapy. However, the number…2022 American Transplant Congress
Estimating the Effect of Increased Donor Heart Ischemic Time on Post-Transplant Survival Using Instrumental Variables
*Purpose: Isolate the impact of organ ischemic time on post-transplant survival using the recent change in heart allocation policy as a natural experiment.*Methods: We examined…2022 American Transplant Congress
Noroviral Diarrhea in Solid Organ Transplant Recipients: Characteristics, Interventions and Outcomes
University of Minnesota, Minneapolis, MN
*Purpose: Norovirus may result in significant morbidity in solid organ transplant (SOT) recipients. There is limited evidence for therapeutics beyond supportive care for the management…2022 American Transplant Congress
Favorable Outcomes in Older Diabetics Receiving a Simultaneous Kidney Pancreas Transplant Compared to Those Receiving a Living Donor Kidney Transplant
1Mayo Clinic, Phoenix, AZ, 2Mayo Clinic, Rochester, MN
*Purpose: To compare the long-term outcomes of older (50-65 yr) diabetic patients who received Simultaneous Kidney pancreas transplantation (SKP) vs. living donor (LD) kidney transplants.*Methods:…2022 American Transplant Congress
Cardiac Catheterization in ESKD Patients with High Cardiovascular Risk Prior to Kidney Transplantation
*Purpose: Cardiovascular disease is the leading cause of death after kidney transplantation (KT), with a high risk of myocardial infarction (MI) in the peri-transplantation period.…2022 American Transplant Congress
One-Year Outcomes in Kidney Transplant Recipients with Acute Kidney Injury and COVID-19
*Purpose: Acute kidney injury (AKI) occurs in more than half of kidney transplant recipients (KTRs) with COVID-19. The longitudinal trajectory of kidney function is unclear.…2022 American Transplant Congress
Sarcopenia and Testosterone Deficiency with Chronic Liver Disease; Post-Liver Transplant Utility of Short Term Testosterone Replacement Therapy
1Penn State Health Milton S. Hershey Medical Center, Hershey, PA, 2Presbyterian, New York, NY
*Purpose: Chronic liver disease is often associated with testosterone deficiency. However, testosterone therapy does not improve survival. So far, after a successful liver transplant (LTx),…2022 American Transplant Congress
Moving Beyond the Waitlist in Measurement of Access in Kidney Transplantation
University of British Columbia, Vancouver, BC, Canada
*Purpose: Studies limited to waitlist candidates have suggested better access to kidney transplantation and fewer disparities in acesss since the new kidney allocation system (KAS)…2022 American Transplant Congress
Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for T2 Hepatocellular Carcinoma and May Allow for Decreased Mortality
*Purpose: Prior studies have suggested that induction therapy leads to worse outcomes after liver transplantation (LT) for hepatocellular carcinoma (HCC). This study evaluated the impact…2022 American Transplant Congress
Post-Allocation Policy and Changes in Gender Disparities in Access to Simultaneous Liver and Kidney Transplantation
*Purpose: Gender-based differences in receiving simultaneous liver-kidney transplant (SLKT) is not well-understood. We recently found that women are disadvantaged in access to SLKT, especially women…
- 1
- 2
- 3
- …
- 66
- Next Page »